Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Y F Zeng

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Laryngoscope|June 29, 2026
Awake Blue Light vs. KTP Laser Treatment for Vocal Fold Lesions: A Randomized Controlled TrialR Jun Lin, Peter Y F Zeng, Patrick MacInnis, et al.
Msphere|August 11, 2022
The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human CarcinogenesisMikhail Salnikov, Steven F Gameiro, Peter Y F Zeng, et al.
Viruses|December 23, 2023
HPV16 Intratypic Variants in Head and Neck Cancers: A North American PerspectiveSteven F Gameiro, Mikhail Y Salnikov, Peter Y F Zeng, et al.
Communications Medicine|August 3, 2022
Proteome and phosphoproteome signatures of recurrence for HPV<sup>+</sup> head and neck squamous cell carcinomaTomonori Kaneko, Peter Y F Zeng, Xuguang Liu, et al.
Oral Oncology|August 23, 2020
Chromosome 3p loss in the progression and prognosis of head and neck cancerMushfiq Hassan Shaikh, John W Barrett, Mohammed I Khan, et al.
Infectious Agents and Cancer|February 16, 2021
Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosisSteven F Gameiro, Farhad Ghasemi, Peter Y F Zeng, et al.
Cancers|January 24, 2020
Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck CancersMartin A Prusinkiewicz, Steven F Gameiro, Farhad Ghasemi, et al.
Head & Neck|December 15, 2023
A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomasFrancisco Laxague, Peter Y F Zeng, Dorsa Zabihi, et al.
Oral Oncology|April 16, 2025
Molecular features of T and N stage progression in laryngeal cancerNicholas Li, Peter Y F Zeng, Hugh A J Kim, et al.
Oral Oncology|October 1, 2023
Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancerMushfiq H Shaikh, Alice Dawson, Stephenie D Prokopec, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Laryngoscope|June 29, 2026
Awake Blue Light vs. KTP Laser Treatment for Vocal Fold Lesions: A Randomized Controlled TrialR Jun Lin, Peter Y F Zeng, Patrick MacInnis, et al.
Msphere|August 11, 2022
The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human CarcinogenesisMikhail Salnikov, Steven F Gameiro, Peter Y F Zeng, et al.
Viruses|December 23, 2023
HPV16 Intratypic Variants in Head and Neck Cancers: A North American PerspectiveSteven F Gameiro, Mikhail Y Salnikov, Peter Y F Zeng, et al.
Communications Medicine|August 3, 2022
Proteome and phosphoproteome signatures of recurrence for HPV<sup>+</sup> head and neck squamous cell carcinomaTomonori Kaneko, Peter Y F Zeng, Xuguang Liu, et al.
Oral Oncology|August 23, 2020
Chromosome 3p loss in the progression and prognosis of head and neck cancerMushfiq Hassan Shaikh, John W Barrett, Mohammed I Khan, et al.
Infectious Agents and Cancer|February 16, 2021
Low expression of NSD1, NSD2, and NSD3 define a subset of human papillomavirus-positive oral squamous carcinomas with unfavorable prognosisSteven F Gameiro, Farhad Ghasemi, Peter Y F Zeng, et al.
Cancers|January 24, 2020
Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck CancersMartin A Prusinkiewicz, Steven F Gameiro, Farhad Ghasemi, et al.
Head & Neck|December 15, 2023
A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomasFrancisco Laxague, Peter Y F Zeng, Dorsa Zabihi, et al.
Oral Oncology|April 16, 2025
Molecular features of T and N stage progression in laryngeal cancerNicholas Li, Peter Y F Zeng, Hugh A J Kim, et al.
Oral Oncology|October 1, 2023
Loss of LRP1B expression drives acquired chemo and radio-resistance in HPV-positive head and neck cancerMushfiq H Shaikh, Alice Dawson, Stephenie D Prokopec, et al.
Pageof 3